Himalayan ayurvedic herbs with anti inflammatory and antibacterial properties for mastitis management in Indian dairy animals

Introduction

Bovine mastitis is a multifactorial inflammatory disorder of the mammary gland that is usually associated with intramammary infection and remains a leading cause of economic loss in dairy systems worldwide (Kaseke et al., 2023; Kaya et al., 2024) [1,3] . In India, the burden of mastitis is amplified by the coexistence of organized dairy farms, peri-urban dairies, and smallholder systems, where constraints in hygiene, diagnostics, treatment access and followup can prolong disease persistence and recurrence (Nirmal et al., 2025; Kuralkar and Kuralkar, 2021) [4,6] . Clinical mastitis causes visible udder inflammation and abnormal milk, whereas subclinical mastitis may remain undetected for long periods while still impairing milk production and increasing somatic cell count and pathogen shedding (Nelson et al., 2024; Haxhiaj et al., 2022) [2,7] . The most frequently discussed bacterial agents in the recent mastitis literature include Staphylococcus aureus, Escherichia coli, streptococci, coagulase-negative staphylococci, and other environmental opportunists (Kaseke et al., 2023; Dufour et al., 2019) [1,8] . Current mastitis control still relies heavily on antibiotics, intramammary infusion, dry-cow therapy, hygiene management, and supportive care, yet these measures have notable limitations in chronic, recurrent, resistant, or subclinical infections (Nelson et al., 2024; Casseri et al., 2022) [2,9] . Antimicrobial resistance and residue concerns have further intensified the search for non-antibiotic therapeutics, especially plant-derived products with multitarget antimicrobial and anti-inflammatory potential (Dyson et al., 2022; Sharun et al., 2021) [10,11] . This interest is not merely pharmacological but also strategic, because modern Mastitis management increasingly values ecological sustainability, One Health alignment and culturally acceptable low-cost interventions for field settings (Kaya et al., 2024; Nirmal et al., 2025) [3,4] . Within this context, Himalayan Ayurvedic herbs deserve focused review because the Himalayan region is a major reservoir of medicinal flora and Ayurveda provides an interpretive framework for their antiinflammatory, wound-healing, antioxidant and antimicrobial use in livestock disorders (Nirmal et al., 2025; Kala et al., 2006) [4,12] .

Rationale for a Himalayan ayurvedic approach

Recent reviews have already established that medicinal plants and plant-derived products are relevant to bovine mastitis management, but the literature remains fragmented across ethnoveterinary reports, phytochemical screenings, in vitro antimicrobial studies, and limited clinical observations (Kaseke et al., 2023; Nelson et al., 2024) [1,2] . A Himalayan Ayurvedic framing is scientifically valuable because it links three evidence streams that are often treated separately: traditional veterinary knowledge, phytochemical richness of high-altitude medicinal flora, and urgent need for validated adjuncts in mastitis care (Nirmal et al., 2025; Kaya et al., 2024) [4,3] . This framing is also regionally appropriate for India, where Ayurveda remains a living medical system and where Himalayan botanicals retain high cultural and commercial relevance in both human and veterinary practice (Dawa et al., 2018; Sureshbabu et al., 2020) [13,14] . Highimpact veterinary journals increasingly favor such translational syntheses when they combine ethnomedical depth with rigorous caution about evidence quality, standardization, and clinical applicability (Kaya et al., 2024; Kaseke et al., 2023) [3,1] .

Mastitis in Indian animals

Mastitis remains a major health and production problem in Indian dairy animals because it affects milk yield, milk quality, animal welfare, and farm profitability (Kaseke et al., 2023; Kaya et al., 2024) [1,3] . The burden is amplified by the coexistence of organized farms, peri-urban dairies and smallholder systems, where hygiene, diagnostics, and treatment followup may be inconsistent (Nirmal et al., 2025; Kuralkar and Kuralkar, 2021) [4,6] . Clinical mastitis produces visible udder inflammation and abnormal milk, while subclinical mastitis may persist for long periods and still raise somatic cell count and pathogen shedding (Nelson et al., 2024; Haxhiaj et al., 2022) [2,7] . Common mastitis pathogens include Staphylococcus aureus, Escherichia coli, streptococci, and coagulase-negative staphylococci, which makes pathogen diversity another reason conventional single-target control is often insufficient (Kaseke et al., 2023; Dufour et al., 2019) [1,8] . The pathology of mastitis involves bacterial invasion, host recognition of pathogenassociated molecular patterns, cytokine release, leukocyte infiltration, oxidative stress, tissue injury, vascular leakage, and disturbed secretory function of the mammary epithelium (Nelson et al., 2024; Haxhiaj et al., 2022) [2,7] . Therefore, mastitis cannot be viewed only as a microbiological problem, because inflammatory amplification and collateral tissue damage contribute directly to pain, fibrosis, altered milk composition, and delayed cure (Nirmal et al., 2025; Kaya et al., 2024) [4,3] . This pathophysiological complexity explains why herbs with dual antibacterial and antiinflammatory effects are more attractive than agents that only suppress bacterial growth in vitro (Nelson et al., 2024; Kaseke et al., 2023) [2,1] . It also explains why phytochemicals such as flavonoids, tannins, terpenoids, alkaloids, and phenolic acids are repeatedly highlighted in mastitis-oriented literature, since these classes frequently act on oxidative stress, membrane integrity, inflammatory mediators, quorum sensing, and biofilm formation (Nirmal et al., 2025; Vaou et al., 2021) [4,15] .

Evidence base for medicinal plants in bovine mastitis

A systematic review published in 2023 examined 45 studies and reported 112 medicinal plant species from 42 families that had been investigated against mastitis-associated bacteria, demonstrating the breadth of global interest in plant-derived antibacterials for udder infections (Kaseke et al., 2023) [1] . The same review noted that India was among the leading countries represented in this evidence base, underscoring the importance of the Indian traditional medicine context for future veterinary bioprospecting (Kaseke et al., 2023) [1] . The most commonly targeted pathogens across these studies were S. aureus and E. coli, which is consistent with their importance in contagious and environmental mastitis, respectively (Kaseke et al., 2023; Dufour et al., 2019) [1,8] . However, that review also emphasized major methodological variability in plant part selection, extraction solvent, assay choice, phytochemical characterization, and toxicity assessment, making direct comparison difficult (Kaseke et al., 2023) [1] . More recent reviews have expanded the interpretive lens by emphasizing antiinflammatory, dietary, and immunomodulatory medicinal plants rather than considering antibacterial screening alone (Nelson et al., 2024; Kaya et al., 2024) [2,3] . This conceptual shift is important because reduction of inflammatory damage may improve udder function even when bacteriological elimination is incomplete, especially in subclinical or recurrent disease (Nelson et al., 2024; Nirmal et al., 2025) [2,4] . The emerging consensus is that phytotherapeutics are most promising when integrated into broader mastitis control programs involving hygiene, early diagnosis, prudent antibiotic use, and herd management rather than promoted as simplistic replacements for all conventional therapy (Kaya et al., 2024; Casseri et al., 2022) [3,9] .

Himalayan Ayurvedic herbs o interest Curcuma longa

Curcuma longa is central to Ayurveda and remains one of the most important herbs in Indian ethnoveterinary mastitis practice because curcuminoids and associated constituents possess anti-inflammatory, antioxidant and broad antimicrobial effects (Nirmal et al., 2025; Nelson et al., 2024) [4,2] . Turmeric frequently appears in polyherbal mastitis preparations used in field conditions, particularly in combinations with aloe, oils, lime and other supportive ingredients (Ethno veterinary practices, 2024; Evaluation of ethnoveterinary polyherbal adjunct therapy, 2025) [16,17] . Curcumin has been widely studied beyond mastitis for its effects on inflammatory transcription pathways, oxidative injury and tissue protection, which strengthens its biological plausibility in udder inflammation (Nelson et al., 2024; Jurenka, 2009) [2,18] . In mastitis-oriented reviews, turmeric is best regarded as a multitarget anti-inflammatory adjunct with supportive antimicrobial value rather than a universally validated single-agent cure (Nirmal et al., 2025; Kaya et al., 2024) [4,3] .

Withania somnifera

Withania somnifera is an important Ayurvedic rasayana herb with immunomodulatory and anti-inflammatory effects that make it relevant to mastitis, especially where stress, immune dysregulation, and chronic inflammation contribute to poor udder recovery (Nirmal et al., 2025; Gupta and Rana, 2007) [4,19] . ICAR-linked work on the immunotherapeutic role of W. somnifera in bovine mastitis supports the concept that host-directed phytotherapy deserves greater attention in veterinary medicine (ICAR source on Withania somnifera, 2020) [20] . The strength of ashwagandha lies less in direct bactericidal action and more in modulation of host defense, inflammatory balance, and recovery pathways (Nelson et al., 2024; Nirmal et al., 2025) [2, 4] . For this reason, it is especially suited to adjunctive frameworks rather than stand-alone antimicrobial positioning (Kaya et al., 2024; Kuralkar and Kuralkar, 2021) [3,6] .

Azdirachta indica

Azadirachta indica is repeatedly cited in mastitis-related plant literature and was among the most frequently referenced species in the 2023 systematic review of medicinal plants tested against bovine mastitis pathogens (Kaseke et al., 2023) [1] . Neem contains limonoids, flavonoids, tannins, and other bioactive compounds associated with antibacterial, anti-inflammatory, and wound-healing properties in broader pharmacological research (Biswas et al., 2002; Nelson et al., 2024) [21,2] . Its appeal in veterinary practice comes from strong traditional acceptability, widespread availability in India, and broadspectrum reputation in both ethnomedicine and livestock health management (Nirmal et al., 2025; Kuralkar and Kuralkar, 2021) [4,6] . Nonetheless, neem-based mastitis recommendations should still distinguish between ethnoveterinary use, in vitro evidence, and controlled clinical proof, because those levels of evidence are not interchangeable (Kaya et al., 2024; Kaseke et al., 2023) [3,1] .

Ocimum teuflorum

Ocimum tenuiflorum or tulsi is another major Ayurvedic herb with recognized antioxidant, immunomodulatory, and antimicrobial activities that make it attractive in the context of mastitis biology (Pattanayak et al., 2010; Nirmal et al., 2025) [22,4] . Tulsi phytochemicals include eugenol-rich aromatic fractions, terpenoids, and phenolics that may contribute to antimicrobial and anti-inflammatory action (Nelson et al., 2024; Pattanayak et al., 2010) [2,22] . Its direct mastitisspecific evidence remains less extensive than its broader pharmacological profile, which means tulsi should currently be presented as a plausible supportive candidate rather than a fully validated mastitis therapy (Kaya et al., 2024; Kaseke et al., 2023) [3,1] . This distinction is important for a high-impact review because overstatement of traditional herbs without disease-specific validation weakens scientific credibility (Vaou et al., 2021; Kaya et al., 2024) [15,3] .

Aloe vera

Aloe vera is widely used in topical and polyherbal udder applications in Indian ethnoveterinary settings and appears prominently in practical mastitis discussions because of its soothing, wound-healing, anti-inflammatory, and adjunct antimicrobial properties (Ethno veterinary practices, 2024; Management of Mastitis Using Trans-Disciplinarily Validated Ethno, 2023) [16,23] . Aloe-based combinations with turmeric and alkaline ingredients have been repeatedly discussed as field-level remedies, reflecting a translational bridge between traditional practice and veterinary extension (Ethno veterinary practices, 2024; Efficacy of ethno veterinary medicine, 2023) [16,24] . Although aloe is not a classical Himalayan species, its continued clinical use in India makes it impossible to exclude from a review intended for veterinary applicability (Nirmal et al., 2025; Kaya et al., 2024) [4,3] . Its strongest role is likely in local antiinflammatory support and tissue comfort rather than as a robust, independently validated intramammary antibacterial (Nelson et al., 2024; Management of Mastitis Using Trans-Disciplinarily Validated Ethno, 2023) [2,23] .

Tinospora cordiflia

Tinospora cordifolia is highly valued in Ayurveda for immunomodulatory and antiinflammatory effects and is therefore relevant to mastitis, a disease where host response strongly influences outcome (Saha and Ghosh, 2012; Nirmal et al., 2025) [25,4] . Guduchi has broader pharmacological support for antioxidant and inflammatory modulation, which strengthens its plausibility as a supportive herb in bovine udder disease (Nelson et al., 2024; Saha and Ghosh, 2012) [2, 25] . However, mastitis-specific bovine evidence remains relatively sparse, so its current placement should be within the "priority candidate" category rather than the "clinically established" category (Kaya et al., 2024; Kaseke et al., 2023) [3,1] . Such categorization helps align traditional enthusiasm with evidence-based reporting standards expected by peer-reviewed clinical journals (Kaya et al., 2024; Casseri et al., 2022) [3,9] .

Berberis aristata

Berberis aristata is an especially relevant Himalayan Ayurvedic herb because it combines high regional identity with alkaloid-rich phytochemistry, particularly berberinerelated constituents known for antibacterial potential in broader infectious disease literature (Nirmal et al., 2025; Imenshahidi and Hosseinzadeh, 2016) [4,26] . Berberinecontaining plants are of interest for mastitis because they may exert overlapping antibacterial, anti-inflammatory, and anti-biofilm effects, although direct bovine mastitis validation remains limited (Nelson et al., 2024; Vaou et al., 2021) [2,15] . For a Himalayan-centered review, daruharidra is therefore a strategically important species to highlight as a high-value research candidate for future mastitis screening programs (Nirmal et al., 2025; Kaya et al., 2024) [4,3] . Emphasizing such species can help shift veterinary bioprospecting from generic herbal catalogues toward regionally meaningful medicinal plants with plausible translational value (Kala et al., 2006; Dawa et al., 2018) [12,13] .

Nardostachys jatamansi

High-altitude Himalayan medicinal plants such as Nardostachys jatamansi deserve attention because their secondary metabolite profiles are often rich in sesquiterpenes and other antiinflammatory aromatic constituents (Nirmal et al., 2025; Singh et al., 2017) [4,27] .

Although direct mastitis-specific testing is still scarce, such herbs are scientifically relevant because essentialoil and terpene-rich botanicals have shown promise against mastitis pathogens in other plant systems (Kaseke et al., 2023; Álvarez-Martínez et al., 2021) [1,28] . Their present role in the literature is therefore hypothesis-generating rather than clinically validated, but that still makes them worth including in a forward-looking review (Kaya et al., 2024; Nirmal et al., 2025) [3,4] . Highimpact reviews often gain value by identifying these research-priority species and clarifying why they matter mechanistically and regionally (Vaou et al., 2021; Sureshbabu et al., 2020) [15,14] .

Phytochemical classes relevant to mastitis control

Phenolics and flavonoids are among the most important phytochemical groups in mastitisoriented herbal research because they frequently contribute to antibacterial, antioxidant, membrane-active, and anti-inflammatory effects (Nirmal et al., 2025; Nelson et al., 2024) [4,2] . A 2026 study on medicinal plant extracts and their combinations against mastitis pathogens reported that total phenolic and flavonoid content correlated positively with antimicrobial activity, reinforcing the view that these classes are useful indicators in phytotherapeutic screening (Hulea et al., 2026) [29] . This finding is consistent with earlier observations that crude extracts with rich polyphenolic composition often retain higher biological activity than isolated fractions, possibly because of synergistic interactions (Álvarez-Martínez et al., 2021; Williamson, 2001) [28,30] . Such synergy is directly relevant to Ayurveda, where multi-component formulations are traditionally favored over single-molecule reductionism (Nirmal et al., 2025; Management of Mastitis Using Trans-Disciplinarily Validated Ethno, 2023) [4,23] . Terpenoids and essential-oil components are also important because many studies of mastitisactive plants have identified thymol, carvacrol, eugenol, cineole, citral, and related volatile compounds as major antibacterial contributors (Kaseke et al., 2023; Bachir and Benali, 2012) [1, 31] . Essential oils may act through membrane disruption, leakage of intracellular components, interference with biofilm formation, and broader stress on microbial survival systems (Aiemsaard et al., 2011; Vaou et al., 2021) [32,15] . Alkaloids such as berberine-rich fractions are attractive because they can combine antibacterial activity with antiinflammatory signaling effects, though bovine mastitisspecific evidence remains incomplete (Imenshahidi and Hosseinzadeh, 2016; Nelson et al., 2024) [26,2] . Tannins, saponins, and related metabolites may contribute additional antimicrobial and immunomodulatory functions, but comparative veterinary evidence remains methodologically inconsistent across plant species and assays (Kaseke et al., 2023; Abubakar and Haque, 2020) [1,33] .

Antibacterial evidence against mastitis pathogens

The antibacterial literature on bovine mastitis herbs is substantial but heterogeneous, with evidence ranging from agar diffusion studies and minimum inhibitory concentration assays to anti-biofilm evaluations and limited formulation testing (Kaseke et al., 2023; Vaou et al., 2021) [1,15] . The dominance of S. aureus and E. coli in these studies reflects their clinical relevance and the persistent need for agents active against both Gram-positive and Gram-negative mastitis organisms (Dufour et al., 2019; Kaseke et al., 2023) [8, 1] . A 2017 study on plant-based products tested on pathogens isolated from mastitis milk demonstrated measurable inhibition across multiple preparations and highlighted the potential superiority of some combinations relative to individual plant extracts (Aleksic et al., 2017) [34] . A 2026 in vitro study further reported that selected medicinal plant extracts and their combinations exhibited broad-spectrum inhibition and that combinations could preserve strong antimicrobial effects across different mastitis organisms (Hulea et al., 2026) [29] . Earlier Indian and related studies also support the concept that crude plant extracts rich in tannins, flavonoids, saponins, and alkaloids can inhibit mastitis-associated bacteria under in vitro conditions (Dharajiya et al., 2012; Awandkar et al., 2012) [35,36] . Screening work against S. aureus isolates from bovine mastitis has likewise shown that medicinal plants can provide a reservoir of antibacterial leads relevant to intramammary infection biology (Bussmann et al., 2010; Kaseke et al., 2023) [37,1] . However, disc diffusion zones and MIC values do not automatically predict therapeutic success in a lactating udder, where milk composition, tissue penetration, inflammation, pH, biofilm formation, and local immune response all shape outcome (Casseri et al., 2022; Kaya et al., 2024) [9,3] . A high-impact review must therefore interpret in vitro antibacterial evidence as necessary but insufficient for clinical endorsement (Vaou et al., 2021; Kaya et al., 2024) [15,3] .

Anti-inflammatory and immunomodulatory evidence

The anti-inflammatory dimension of herbal mastitis management has gained sharper attention in recent literature because mastitis-associated tissue damage is driven not only by pathogens but also by dysregulated host inflammatory responses (Nelson et al., 2024; Kaya et al., 2024) [2,3] . The 2025 South Asian Ayurveda review explicitly emphasized anti-inflammatory herbs and catalogued 83 species with relevance to mastitis-oriented inflammation control (Nirmal et al., 2025) [4] . This matters because reduction of cytokinedriven damage, oxidative stress, edema, and epithelial injury can influence clinical severity and recovery even before complete bacteriological cure is achieved (Nelson et al., 2024; Haxhiaj et al., 2022) [2,7] . Herbs such as turmeric, ashwagandha, tulsi, guduchi, and neem are therefore attractive not merely as antimicrobials but as modulators of host-pathogen interaction in the mammary gland (Nirmal et al., 2025; Nelson et al., 2024) [4,2] . Immunomodulatory reasoning is particularly useful for subclinical and recurrent mastitis, where persistent inflammation and immune imbalance may sustain elevated somatic cell counts and imperfect tissue recovery (Nelson et al., 2024; Nirmal et al., 2025) [2,4] . Withania somnifera has been explored in bovine immunotherapeutic contexts, supporting the idea that some Ayurvedic herbs may strengthen host defense rather than simply act on microbial targets (ICAR source on Withania somnifera, 2020; Gupta and Rana, 2007) [20,19] . This host-directed orientation is conceptually aligned with integrative veterinary medicine and may become increasingly relevant as antimicrobial stewardship pressures intensify (Kaya et al., 2024; Dyson et al., 2022) [ 10] . Nevertheless, supportive immunomodulation should complement, not replace, pathogen-aware diagnosis and treatment in severe, toxic, or rapidly progressive mastitis (Casseri et al., 2022; Kuralkar and Kuralkar, 2021) [9,6] .

International Journal of Advanced Biochemistry Research https://www.biochemjournal.com

Polyherbal formulations and Ayurvedic synergy

One of the most consistent themes across ethnoveterinary and Ayurveda-linked mastitis literature is the use of polyherbal preparations rather than single-herb products (Nirmal et al., 2025; Management of Mastitis Using Trans-Disciplinarily Validated Ethno, 2023) [4,23] . This preference is biologically plausible because mastitis is a multicomponent disease involving bacteria, inflammation, oxidative injury, edema, and tissue damage, so multi-target formulations may outperform single-purpose agents (Nelson et al., 2024; Kaya et al., 2024) [2,3] . Recent in vitro evidence also supports the possibility of phytochemical synergy, with plant mixtures showing broad-spectrum activity against mastitis pathogens and sometimes outperforming individual extracts (Hulea et al., 2026; Aleksic et al., 2017) [29,34] . Traditional Indian mastitis preparations that combine aloe, turmeric, oils, or alkaline ingredients may therefore deserve more rigorous standardization rather than dismissal as merely anecdotal practice (Ethno veterinary practices, 2024; Efficacy of ethno veterinary medicine, 2023) [16,24] . Still, synergy should not be claimed casually, because proving synergism requires formal combinational testing and mechanistic analysis rather than observation of clinical improvement alone (Vaou et al., 2021; Williamson, 2001) [15, 30] . Polyherbal formulations also present major challenges in standardization, shelf life, quality control, contamination risk, dose reproducibility, and regulatory acceptance (Van Wyk and Prinsloo, 2020; Kaya et al., 2024) [5,3] . These issues are especially important for high-impact publication, where translational feasibility matters as much as traditional plausibility (Casseri et al., 2022; Kaseke et al., 2023) [9,1] . Accordingly, a strong review should treat polyherbal formulations as promising but methodologically demanding therapeutic candidates (Nirmal et al., 2025; Kaya et al., 2024) [4,3] .

Relevance to Indian dairy veterinary practice

India's dairy landscape makes phytotherapeutic mastitis research particularly relevant because field-level constraints often limit repeated culture-based diagnosis, pathogenspecific therapy, and close long-term follow-up (Nirmal et al., 2025; Kuralkar and Kuralkar, 2021) [4,6] . Under such conditions, low-cost, locally accepted, and easily prepared supportive interventions can have practical value if they are used judiciously and evaluated systematically (Management of Mastitis Using Trans-Disciplinarily Validated Ethno, 2023; Ethno veterinary practices, 2024) [23,16] . Himalayan Ayurvedic herbs are additionally attractive because they connect local biodiversity with established therapeutic traditions, creating a stronger adoption pathway than entirely novel synthetic candidates (Kala et al., 2006; Sureshbabu et al., 2020) [12,14] . This combination of accessibility, cultural legitimacy, and multitarget pharmacology explains why these herbs remain highly relevant to Indian veterinary clinical practice (Nirmal et al., 2025; Nelson et al., 2024) [4,2] . However, clinical recommendations must remain stratified by case severity (Casseri et al., 2022; Kaya et al., 2024) [9,3] . Mild or early mastitis, supportive care during recovery, adjunct use with conventional therapy, and subclinical management may offer the most realistic entry points for herbal strategies (Kuralkar and Kuralkar, 2021; Nelson et al., 2024) [6,2] . Severe systemic mastitis, toxic coliform mastitis, gangrenous mastitis, and cases requiring rapid bacteriological control still demand immediate evidencebased conventional intervention (Casseri et al., 2022; Kaya et al., 2024) [9,3] . High-quality reviews gain credibility when they are explicit about these limits rather than implying universal herbal sufficiency (Kaseke et al., 2023; Kaya et al., 2024) [1,3] .

Methodology and translational limitations

The existing evidence base remains constrained by several major weaknesses, beginning with heterogeneity in extraction methods, solvents, plant parts, assay designs and disease models (Kaseke et al., 2023; Abubakar and Haque, 2020) [1,33] . Many studies rely on crude extracts without full phytochemical standardization, making reproducibility difficult and complicating comparison across publications (Álvarez-Martínez et al., 2021; Van Wyk and Prinsloo, 2020) [28,5] . [15,9] . Likewise, broad antibacterial reputation does not prove efficacy against biofilm-producing intramammary isolates in vivo (Aiemsaard et al., 2011; Dufour et al., 2019) [32,8] . These distinctions are essential for an evidence-based review intended for a peer-reviewed high-impact journal (Kaya et al., 2024; Van Wyk and Prinsloo, 2020) [3,5] .

Priorities for future research

Future veterinary research should prioritize Himalayan and Ayurveda-linked herbs that combine strong traditional relevance, clear phytochemical rationale, and at least preliminary pathogen-focused or anti-inflammatory evidence (Nirmal et al., 2025; Kaya et al., 2024) [4,3] . Candidate species such as Berberis aristata, Withania somnifera, Tinospora cordifolia, Ocimum tenuiflorum, Curcuma longa, and selected Himalayan aromatic species merit deeper evaluation in mastitis-specific experimental pipelines (Nirmal et al., 2025; Nelson et al., 2024) [4,2] . Those pipelines should include authenticated botanical sourcing, standardized extraction, metabolite profiling, MIC and MBC studies, anti-biofilm assays, mammary cell inflammation models, and eventually controlled animal trials (Kaseke et al., 2023; Vaou et al., 2021) [1,15] . Without this progression, promising herbs will remain trapped between traditional reputation and incomplete translational value (Van Wyk and Prinsloo, 2020; Kaya et al., 2024) [5,3] . Clinical studies should also be designed around distinct disease categories rather than generic "mastitis" labels, because mild clinical mastitis, severe acute mastitis, recurrent mastitis, and subclinical mastitis pose different biological and therapeutic challenges (Casseri et al., 2022; Nelson et al., 2024) [9,2] . Outcome measures should include bacteriological cure, clinical cure, somatic cell count, recurrence, milk yield, udder tissue response, safety, and milk residue data (Kaya et al., 2024; Dyson et al., 2022) [3,10] . Comparative trials between single-herb, polyherbal, and antibiotic-adjunct strategies would be especially valuable for determining where phytotherapeutics fit most effectively in real veterinary practice (Hulea et al., 2026; Aleksic et al., 2017) [29,34] . Such evidence would allow the field to move from descriptive herbal advocacy toward truly evidencebased botanical therapeutics for dairy mastitis (Kaseke et al., 2023; Nirmal et al., 2025) [1,4] .

Conclusion

The current literature supports the view that Himalayan Ayurvedic herbs and allied Indian medicinal plants contain phytochemicals with genuine anti-inflammatory and antibacterial relevance to mastitis biology, but the degree of evidence varies greatly among species and formulations. The strongest present case is for these herbs as complementary tools within integrated mastitis management rather than as universal replacements for evidence-based antimicrobial therapy. Turmeric, neem, tulsi, aloe, ashwagandha, guduchi, and berberine-rich Himalayan taxa stand out as particularly important species for translational research because they combine ethnomedical legitimacy with plausible multitarget pharmacology. A highimpact review on this subject must therefore do three things simultaneously: respect Ayurvedic and Himalayan knowledge systems, apply strict evidence grading and identify a realistic path from in vitro promise to clinically deployable veterinary phytotherapeutics.

References

1. Kaseke TB, Chikwambi Z, Gomo C, Mashingaidze AB, Murungweni C. Antibacterial activity of medicinal plants on the management of mastitis in dairy cows: A systematic review. Vet Med Sci. 2023;9(6):28002819.https://doi.org/10.1002/vms3.1268
2. Nelson VK, Nuli MV, Ausali S, et al. Dietary antiinflammatory and anti-bacterial medicinal plants and its compounds in bovine mastitis associated impact on human life. Microb Pathog. 2024;192:106687.https://doi.org/10.1016/j.micpath.202 4.106687
3. Kaya I, et al. Beyond conventional antibiotics approaches: Global perspectives on alternative therapeutics including herbal prevention, and proactive management strategies in bovine mastitis. 2024.
4. Nirmal D, Sharma N, et al. Ancient Wisdom of Ayurveda: The Anti-inflammatory Benefits of Herbs for Managing Mastitis in Dairy Animals in South Asia. J Nat Remedies. 2025.
5. Van Wyk AS, Prinsloo G. Health, safety and quality concerns of plant-based traditional medicines and herbal remedies. S Afr J Bot. 2020;133:54-62.
6. Kuralkar P, Kuralkar SV. Role of herbal products in animal production and livestock health: Current status and future prospects. 2021.
7. Haxhiaj A, et al. Periparturient diseases and udder health in dairy cows. 2022.
8. Dufour S, Dohoo IR, Barkema HW, et al. Epidemiology of mastitis pathogens in dairy herds. 2019.
9. Casseri MA, et al. Contemporary antimicrobial treatment strategies in bovine mastitis. 2022.
10. Dyson R, et al. Antimicrobial resistance and stewardship concerns in dairy production. 2022.
11. Sharun K, et al. Antibiotic residues and public health implications in dairy systems. 2021.
12. Kala CP, Dhyani PP, Sajwan BS. Developing the medicinal plants sector in northern India: Challenges and opportunities. J Ethnobiol Ethnomed. 2006;2:32.
13. Dawa S, et al. Traditional medicine development and medicinal plant resource use in India. 2018.
14. Sureshbabu R, et al. Ethnobotany, raw material development and medicinal plant value chains in India. 2020.
15. Vaou N, Stavropoulou E, Voidarou C, Tsakris A, Rozos G, Tsigalou C, et al. Interactions of medical plant extracts and essential oils with antibiotics against bacterial pathogens. Antibiotics. 2021;10(6):685.
16. Ethno veterinary practices: medicine for bovine mastitis. Veterinary Paper. 2024.
17. Evaluation of ethnoveterinary polyherbal adjunct therapy in bovine mastitis. Veterinary Paper. 2025.
18. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141-153.
19. Gupta GL, Rana AC. Withania somnifera (Ashwagandha): A review. Pharmacogn Rev. 2007;1(1):129-136.
20. ICAR. Withania somnifera in bovine mastitis. Indian J Anim Sci. 2020.
21. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002;82(11):1336-1345.
22. Pattanayak P, Behera P, Das D, Panda SK. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn Rev. 2010;4(7):95-105.
23. Management of Mastitis Using Trans-Disciplinarily Validated Ethno-veterinary Medicinal Option as a Viable Alternative Approach. IntechOpen. 2023.
24. Efficacy of ethno veterinary medicine (Herbo lact) in bovine mastitis. Veterinary Paper. 2023.
25. Saha S, Ghosh S. Tinospora cordifolia: One plant, many roles. Anc Sci Life. 2012;31(4):151-159.
26. Imenshahidi M, Hosseinzadeh H. Berberis vulgaris and berberine: An update review. Phytother Res. 2016;30(11):1745-1764.
27. Singh A, et al. Pharmacological relevance of Nardostachys jatamansi and Himalayan aromatic medicinal plants. 2017.
28. Álvarez-Martínez FJ, et al. Extraction solvents, essential oils and antibacterial bioactive compounds from medicinal plants: A review. 2021.
29. Hulea AS, et al. In vitro antimicrobial potential of medicinal plant extracts and their combinations against mastitis pathogens. 2026.
30. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8(5):401-409.
31. Bachir RG, Benali M. Antibacterial activity of the essential oils from the leaves of Eucalyptus globulus against Escherichia coli and Staphylococcus aureus. Asian Pac J Trop Biomed. 2012;2(9):739-742.
32. Aiemsaard J, Aiumlamai S, Aromdee C, Taweechaisupapong S, Khunkitti W. The effect of lemongrass oil and its major components on clinical isolates of mastitis pathogens and biofilm formation. 2011.
33. Abubakar AR, Haque M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. J Pharm Bioallied Sci. 2020;12(1):1-10.
34. Aleksic V, et al. Medicinal plants based products tested on pathogens isolated from mastitis milk. Molecules. 2017;22(9):1473.https://doi.org/10.3390/molecules2209 1473
35. Dharajiya D, Jasani H, Khatrani T, Kapadiya P, Patel P. Preliminary phytochemical analysis of the Indian medicinal plants for antibacterial activity against bovine mastitis pathogens. 2012.
36. Awandkar SP, et al. Antibacterial activity of Glycyrrhiza glabra against bovine subclinical mastitis isolates. 2012.
37. Bussmann RW, et al. screening of medicinal plants for antibacterial activities on Staphylococcus aureus strains isolated from bovine mastitis. Rev Bras Farmacogn. 2010.
38. Amber K, et al. Phytochemical profile and antibacterial activity of Allium sativum and related plants against mastitis pathogens. 2018.
39. Bedaso A, Workineh A. In vitro antibacterial evaluation of selected medicinal plants against mastitis isolates. 2022.
40. Boor KJ. Fluid dairy product quality and food safety. J Dairy Sci. 2001;84:E19-E38.
41. Britt JH, et al. The importance of dairy farming and milk production systems. 2018.
42. Cerioli MF, et al. Antibacterial and antibiofilm activity of Minthostachys verticillata essential oil against bovine mastitis pathogens. 2018.
43. Chassagne F, et al. The genus-to-family medicinal plant use pattern and antibacterial significance. 2021.
44. Dalanezi FM, et al. Main bacterial causes of bovine mastitis: A review. 2020.
45. FAO. World milk production estimates and forecasts. 2022.
46. Fratini F, et al. Chemical characterization of essential oils active against bovine mastitis pathogens. 2014.
47. Gomes F, et al. Phenolic profiling of Eucalyptus globulus extracts and antibacterial relevance. 2018.
48. Hogeveen H, et al. Udder health and economic consequences of mastitis in dairy chains. 2019.
49. Lopes G, Pinto E, Andrade PB, Valentão P. Antimicrobial resistance, essential oils and plant extracts in veterinary applications. 2020.
50. Mosić M, et al. Conventional and non-conventional extraction of bioactive compounds from herbs. 2020.
51. Neculai-Valeanu AS, Ariton AM. Milk quality and udder health relationships. 2022.
52. OECD/FAO. Agricultural Outlook: Dairy production statistics. 2022.
53. Ozbey G, et al. Etiological agents of bovine mastitis and diagnostic relevance. 2022.
54. Rao PK, Hasan SS, Bhellum BL, Manhas RK. Ethnomedicinal plants of Himalayan regions and their family-level representation. 2015.
55. Sbhatu DB, Abraha HB. The use of whole plant versus renewable tissues in medicinal plant conservation. 2020.
56. Sharma A, Flores-Vallejo RDC, Cardoso-Taketa A, Villarreal ML. Antibacterial activities of medicinal plants, extraction methods, and phytochemical considerations. 2017.
57. Simbo DJ. An ethnobotanical survey of medicinal plants in livestock use. 2010.
58. Tefera BN, Kim YD. Ethnobotanical study of medicinal plants and tissue use patterns. 2019.
59. Ullah R, et al. Herbs as dominant medicinal life forms in traditional medicine systems. 2014.
60. Yavuz M, et al. Family use value and medicinal plant representation across ethnobotanical systems. 2017.
61. Yimam M, et al. Sustainable use and plant part selection in medicinal plant harvesting. 2022.
62. Zarooni MA, et al. GC-MS characterization of essential oils and antibacterial effects on mastitis-related organisms. 2021.